Y-MABS THERAPEUTICS INC

CUSIP: 984241109 Class: Common Stock

Paradigm Biocapital Advisors LP's Holding History (CIK: 0001855655)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 4,236,346 Value ($000) $19,106 Avg Close Range
Q1 2025
Shares 4,236,346 Value ($000) $18,767 Avg Close Range
Q4 2024
Shares 4,236,346 Value ($000) $33,171 Avg Close Range
Q3 2024
Shares 4,086,346 Value ($000) $53,735 Avg Close Range
Q2 2024
Shares 3,870,594 Value ($000) $46,757 Avg Close Range
Q1 2024
Shares 2,233,610 Value ($000) $36,318 Avg Close Range